Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Change in Taxes: 2016-2021

Historic Change in Taxes for Altimmune (ALT) over the last 6 years, with Sep 2021 value amounting to $2.6 million.

  • Altimmune's Change in Taxes rose 276.83% to $2.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.3 million, marking a year-over-year decrease of 37.18%. This contributed to the annual value of $7.1 million for FY2020, which is 1977.90% up from last year.
  • According to the latest figures from Q3 2021, Altimmune's Change in Taxes is $2.6 million, which was up 356.26% from -$1.0 million recorded in Q2 2021.
  • Altimmune's 5-year Change in Taxes high stood at $3.4 million for Q1 2020, and its period low was -$2.9 million during Q2 2018.
  • Moreover, its 3-year median value for Change in Taxes was $135,274 (2021), whereas its average is $769,769.
  • As far as peak fluctuations go, Altimmune's Change in Taxes crashed by 662.91% in 2018, and later surged by 10,982.67% in 2020.
  • Altimmune's Change in Taxes (Quarterly) stood at $1.3 million in 2017, then crashed by 118.79% to -$237,442 in 2018, then tumbled by 42.98% to -$339,501 in 2019, then surged by 562.13% to $1.6 million in 2020, then surged by 276.83% to $2.6 million in 2021.
  • Its last three reported values are $2.6 million in Q3 2021, -$1.0 million for Q2 2021, and $135,274 during Q1 2021.